Search

Peptide

Reference library

Educational peptide reference — research use only.

Research & educational use only

For laboratory and educational research only. Not for human or veterinary consumption. This is not medical advice. Always follow applicable laws and consult qualified professionals.

The calculator performs unit math for research reference. It must not be used to plan or guide dosing in humans or animals. Verify all figures independently in your lab protocol.

Cartalax

A short bioregulator peptide studied in cartilage and connective-tissue research.

Half-life (approx.)
Short peptide — minutes to hours (approx.)
Diluent
Bacteriostatic water (0.9% benzyl alcohol)
Common vials
10, 20 mg

Half-life figures are literature approximations for educational reference — not pharmacokinetic advice.

Overview

Cartalax is a short Khavinson-class bioregulator peptide (Ala-Glu-Asp) studied in cartilage and connective-tissue aging models. Research is primarily preclinical with emphasis on matrix maintenance gene expression. Short Khavinson-class bioregulator tripeptide focused on cartilage matrix gene expression.

Structure & identity

Tripeptide Ala-Glu-Asp (bioregulator)

Sequence / structure
Tripeptide Ala-Glu-Asp (bioregulator)

Mechanism

Short bioregulator tripeptide modulating chondrocyte gene expression in cartilage-aging models. Chondrocyte culture work examines aggrecan and collagen type II transcript levels.

Studies & clinical programs

  • Cartilage explant culture

    Published research models

    • Peer-reviewed literature documents endpoints under Cartilage explant culture experimental designs.
  • Aging connective tissue models

    Published research models

    • Peer-reviewed literature documents endpoints under Aging connective tissue models experimental designs.

Research models in literature

  • Cartilage explant culture
  • Aging connective tissue models

Literature highlights

  • Tripeptide bioregulator modulates chondrocyte gene expression in cartilage-aging models.
  • Connective-tissue explant cultures used for matrix gene readouts.
  • Grouped with other short Khavinson-class peptides in aging connective-tissue research.

Combination research notes

Grouped with epitalon and GHK-Cu in connective-tissue aging research lists.

Key targets & pathways

Cartilage matrix genesAggrecanChondrocyte senescence

Research areas

CartilageBioregulatorsConnective tissue

Routes in research literature

Subcutaneous

Also known as

Bioregulator peptide

Stability & storage phases

PhaseConditionGuidance
LyophilizedSealed vial, refrigerated (2–8 °C)Intact lyophilized cake or powder is typically stable for months to years per published stability data; protect from moisture, light, and repeated freeze-thaw of the dry vial.
ReconstitutedBacteriostatic water (0.9% benzyl alcohol), refrigeratedMost aqueous peptide solutions remain usable for approximately 2–4 weeks refrigerated; verify published stability data and label with reconstitution date.
Working aliquotsPre-drawn syringes or microtubes, frozen (−20 °C)Aliquot promptly after mixing to limit freeze-thaw cycles on the main vial; thaw once and use to reduce protease-mediated degradation.

Stability windows are formulation-dependent — verify published data and your lab SOP.

Reconstitution reference table

Vial (mg)Diluent (mL)mcg/mLUnits @ 100 mcgUnits @ 250 mcgUnits @ 500 mcg
1025000.02510
20210000.012.55

U-100 insulin syringe scale (100 units = 1 mL). Illustrative only — not dosing guidance.

Reconstitution steps

  1. Allow vial to reach room temperature (15–30 min)
  2. Swab rubber stopper with alcohol prep pad
  3. Draw calculated bacteriostatic water into syringe
  4. Inject diluent slowly down vial wall — do not spray directly onto cake
  5. Gently swirl until fully dissolved — do not shake vigorously
  6. Label with date, concentration, and diluent volume
  7. Refrigerate and use within your lab stability window

Often reconstituted with 1–2 mL bacteriostatic water.

Laboratory record checklist

  • Compound identity recorded in lab notebook (name, lot, preparation date)
  • Analytical identity cross-checked against published sequence or structure
  • Potency or concentration documented from analytical certificate when available
  • Purity or HPLC data filed when provided with research material
  • Appearance noted: intact lyophilized cake or uniform powder
  • Sterility / endotoxin report archived when available
  • Storage temperature applied immediately per published stability guidance